血栓性淺靜脈炎的新見解_《中國普外基礎與臨床雜志》

作者：

吳夢濤 ¹ , 李凡東 ¹ , 金星 ²

1.濟南軍區總醫院普外科血管外科病區（山東濟南 250031）;;
2.山東省立醫院血管外科（山東濟南 250021）;

關鍵詞：

血栓性淺靜脈炎淺靜脈血栓抗凝治療淺靜脈曲張

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 吳夢濤,李凡東,金星. 血栓性淺靜脈炎的新見解. 中國普外基礎與臨床雜志, 2012, 19(9): 1012-1014. doi: 復制

1.	Widmer LK， Stfihelin HB， NissenC， et al. Prospektiv-epidemiologische Untersuchung， Basler Studie Ⅰ-Ⅲ 1959-1978[M]. Bern Stuttgart Wien， Hans Huber， 1981：10-17.
2.	Unno N， Mitsuoka H， Uchiyama T， et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins[J]. Surg Today， 2002， 32(5)：397-401.
3.	Decousus H， Epinat M， Guillot K， et al. Superficial vein thrombosis：risk factors， diagnosis， and treatment[J]. Curr Opin Pulm Med， 2003， 9(5)： 393-397.
4.	Beatty J， Fitridge R， Benveniste G， et al. Acute superficialvenous thrombophlebitis：does emergency surgery have a role?[J]. Int Angiol， 2002， 21(1)：93-95.
5.	Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin， a nonsteroidal anti-inflammatory agent， and placebo in the treatment of superficial vein thrombosis[J]. Arch Intern Med， 2003， 163(14)：1657-1663.
6.	Sobreira ML， Yoshida WB， Lastoria. Superficial thrombophlebitis：epidemiology， physiopathology， diagnosis and treatment[J]. J Vasc Bras， 2008， 7(2)：131-143.
7.	Segal JB， Brotman DJ， Necochea AJ， et al. Predictive value of factorⅤLeiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation：a systematic review[J]. JAMA， 2009， 301(23)：2472-2485.
8.	Martinelli I， Battaglioli T， Razzari C， et al. Type and location of venous thromboembolism in patients with factorⅤ Leiden or prothrombin G20210A and in those with no thrombophilia[J]. J Thromb Haemost， 2007， 5(1)：98-101.
9.	Schönauer V， Kyrle PA， Weltermann A， et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism[J]. J Vasc Surg， 2003， 37(4)：834-838.
10.	Kovac M， Mitic G， Mikovic Z， et al. Type and location ofvenous thromboembolism in carriers of FactorⅤLeiden or prothrombin G20210A mutation versus patients with no mutation[J]. Clin Appl Thromb Hemost， 2010， 16(1)：66-70.
11.	Middeldorp S. Evidence-based approach to thrombophilia testing[J]. J Thromb Thrombolysis， 2011， 31(3)：275-281.
12.	Leong DP， Dundon BK， Worthley MI. Trousseau’s syndrome[J]. Intern Med J， 2011， 41(3)：289.
13.	Kondo T. Traumatic funicular phlebitis of the thoracic wallresembling Mondor’s disease：a case report[J]. J Med Case Rep， 2011， 5：127.
14.	Kahn JB， Baharestani S， Beck HC， et al. Orbital dissemination of Lemierre syndrome from gram-positive septic emboli[J]. Ophthal Plast Reconstr Surg， 2011， 27(3)：e67-e68.
15.	Fazeli B， Modaghegh H， Ravrai H， et al. Thrombophlebitis migrans as a footprint of Buerger’s disease：a prospective-descriptive study in north-east of Iran[J]. Clin Rheumatol， 2008， 27(1)：55-57.
16.	Decousus H， Quéré I， Presles E， et al. Superficial venous thrombosis and venous thromboembolism：a large， prospective epidemiologic study[J]. Ann Intern Med， 2010， 152(4)：218-224.
17.	Milio G， Siragusa S， Minà C， et al. Superficial venous thrombosis：prevalence of common genetic risk factors and their role on spreading to deep veins [J]. Thromb Res， 2008， 123(2)：194-199.
18.	梁勇，金星. 下肢血栓性淺靜脈炎并發肺栓塞[J]. 中國普通外科雜志， 2006， 15(1)：23-75.
19.	Kitchens CS. How I treat superficial venous thrombosis[J]. Blood， 2011， 117(1)：39-44.
20.	Cesarone MR， Belcaro G， Agus G， et al. Management of superficial vein thrombosis and thrombophlebitis：status and expert opinion document[J]. Angiology， 2007， 58 Suppl 1：7S-15S.
21.	van Weert H， Dolan G， Wichers I， et al. Spontaneous superficial venous thrombophlebitis：does it increase risk for thromboembolism? A historic follow-up study in primary care[J]. J Fam Pract， 2006， 55(1)：52-57.
22.	Prandoni P， Tormene D， Pesavento R；Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs：a double-blind， randomized trial[J]. J Thromb Haemost， 2005， 3(6)：1152-1157.
23.	Marchiori A， Verlato F， Sabbion P， et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective， controlled， randomized study[J]. Haematologica， 2002，， 87(5)：523-527.
24.	Kearon C，Kahn SR， Agnelli G， et al. Antithrombotic therapy for venous thromboembolic disease：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest， 2008， 133(6 Suppl)：454S-545S.
25.	Decousus H， Prandoni P， Mismetti P， et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs[J]. N Engl J Med， 2010， 363(13)：1222-1232.
26.	Lee JT， Kalani MA. Treating superficial venous thrombophlebitis[J]. J Natl Compr Canc Netw， 2008， 6(8)：760-765.
27.	Lozano FS， Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis：a prospective study[J]. Vasc Endovascular Surg， 2003， 37(6)：415-420.
28.	王霆. 刺血拔罐治療血栓性淺靜脈炎[J]. 中國針灸， 2011， 31(1)：22.

1. Widmer LK， Stfihelin HB， NissenC， et al. Prospektiv-epidemiologische Untersuchung， Basler Studie Ⅰ-Ⅲ 1959-1978[M]. Bern Stuttgart Wien， Hans Huber， 1981：10-17.
2. Unno N， Mitsuoka H， Uchiyama T， et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins[J]. Surg Today， 2002， 32(5)：397-401.
3. Decousus H， Epinat M， Guillot K， et al. Superficial vein thrombosis：risk factors， diagnosis， and treatment[J]. Curr Opin Pulm Med， 2003， 9(5)： 393-397.
4. Beatty J， Fitridge R， Benveniste G， et al. Acute superficialvenous thrombophlebitis：does emergency surgery have a role?[J]. Int Angiol， 2002， 21(1)：93-95.
5. Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin， a nonsteroidal anti-inflammatory agent， and placebo in the treatment of superficial vein thrombosis[J]. Arch Intern Med， 2003， 163(14)：1657-1663.
6. Sobreira ML， Yoshida WB， Lastoria. Superficial thrombophlebitis：epidemiology， physiopathology， diagnosis and treatment[J]. J Vasc Bras， 2008， 7(2)：131-143.
7. Segal JB， Brotman DJ， Necochea AJ， et al. Predictive value of factorⅤLeiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation：a systematic review[J]. JAMA， 2009， 301(23)：2472-2485.
8. Martinelli I， Battaglioli T， Razzari C， et al. Type and location of venous thromboembolism in patients with factorⅤ Leiden or prothrombin G20210A and in those with no thrombophilia[J]. J Thromb Haemost， 2007， 5(1)：98-101.
9. Schönauer V， Kyrle PA， Weltermann A， et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism[J]. J Vasc Surg， 2003， 37(4)：834-838.
10. Kovac M， Mitic G， Mikovic Z， et al. Type and location ofvenous thromboembolism in carriers of FactorⅤLeiden or prothrombin G20210A mutation versus patients with no mutation[J]. Clin Appl Thromb Hemost， 2010， 16(1)：66-70.
11. Middeldorp S. Evidence-based approach to thrombophilia testing[J]. J Thromb Thrombolysis， 2011， 31(3)：275-281.
12. Leong DP， Dundon BK， Worthley MI. Trousseau’s syndrome[J]. Intern Med J， 2011， 41(3)：289.
13. Kondo T. Traumatic funicular phlebitis of the thoracic wallresembling Mondor’s disease：a case report[J]. J Med Case Rep， 2011， 5：127.
14. Kahn JB， Baharestani S， Beck HC， et al. Orbital dissemination of Lemierre syndrome from gram-positive septic emboli[J]. Ophthal Plast Reconstr Surg， 2011， 27(3)：e67-e68.
15. Fazeli B， Modaghegh H， Ravrai H， et al. Thrombophlebitis migrans as a footprint of Buerger’s disease：a prospective-descriptive study in north-east of Iran[J]. Clin Rheumatol， 2008， 27(1)：55-57.
16. Decousus H， Quéré I， Presles E， et al. Superficial venous thrombosis and venous thromboembolism：a large， prospective epidemiologic study[J]. Ann Intern Med， 2010， 152(4)：218-224.
17. Milio G， Siragusa S， Minà C， et al. Superficial venous thrombosis：prevalence of common genetic risk factors and their role on spreading to deep veins [J]. Thromb Res， 2008， 123(2)：194-199.
18. 梁勇，金星. 下肢血栓性淺靜脈炎并發肺栓塞[J]. 中國普通外科雜志， 2006， 15(1)：23-75.
19. Kitchens CS. How I treat superficial venous thrombosis[J]. Blood， 2011， 117(1)：39-44.
20. Cesarone MR， Belcaro G， Agus G， et al. Management of superficial vein thrombosis and thrombophlebitis：status and expert opinion document[J]. Angiology， 2007， 58 Suppl 1：7S-15S.
21. van Weert H， Dolan G， Wichers I， et al. Spontaneous superficial venous thrombophlebitis：does it increase risk for thromboembolism? A historic follow-up study in primary care[J]. J Fam Pract， 2006， 55(1)：52-57.
22. Prandoni P， Tormene D， Pesavento R；Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs：a double-blind， randomized trial[J]. J Thromb Haemost， 2005， 3(6)：1152-1157.
23. Marchiori A， Verlato F， Sabbion P， et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective， controlled， randomized study[J]. Haematologica， 2002，， 87(5)：523-527.
24. Kearon C，Kahn SR， Agnelli G， et al. Antithrombotic therapy for venous thromboembolic disease：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest， 2008， 133(6 Suppl)：454S-545S.
25. Decousus H， Prandoni P， Mismetti P， et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs[J]. N Engl J Med， 2010， 363(13)：1222-1232.
26. Lee JT， Kalani MA. Treating superficial venous thrombophlebitis[J]. J Natl Compr Canc Netw， 2008， 6(8)：760-765.
27. Lozano FS， Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis：a prospective study[J]. Vasc Endovascular Surg， 2003， 37(6)：415-420.
28. 王霆. 刺血拔罐治療血栓性淺靜脈炎[J]. 中國針灸， 2011， 31(1)：22.

《中國普外基礎與臨床雜志》

血栓性淺靜脈炎的新見解

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

血栓性淺靜脈炎的新見解

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料